Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulodexide for Recurrent VTE Prevention in Elderly
NCT04257487Phase 3Recruiting
- Sponsor
- Fondazione Arianna Anticoagulazione
- Start
- Dec 2020
- Primary completion
- Dec 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulodexide in venous thromboembolism (VTE), sponsored by Fondazione Arianna Anticoagulazione. Started Dec 2020; status: recruiting.
02
Drugs
sulodexide
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04257487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04257487.